POLE and neoplasm: In the present cohort of SWI/SNF‐deficient DDEC/UEC, we found that all stage I/II patients with recurrent disease and all patients presenting with extrauterine tumor spread (stage III or IV disease, excluding the single stage IV case with POLE mutation) succumbed to their disease within a year after initial diagnosis.